223 related articles for article (PubMed ID: 34308750)
21. Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis.
Mei H; Liu Y; Zhou Q; Hu K; Liu Y
Biomark Med; 2019 Jan; 13(1):45-54. PubMed ID: 30561226
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and immunological role of Fam20C in pan-cancer.
Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.
Li Y; Jiang T; Zhou W; Li J; Li X; Wang Q; Jin X; Yin J; Chen L; Zhang Y; Xu J; Li X
Nat Commun; 2020 Feb; 11(1):1000. PubMed ID: 32081859
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
Tian X; Xu G
BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis.
Sun KK; Hu PP; Xu F
J Cell Biochem; 2018 Apr; 119(4):3099-3110. PubMed ID: 29058818
[TBL] [Abstract][Full Text] [Related]
27. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
Wei Y; Niu B
Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease.
Wu Y; Huang C; Meng X; Li J
Curr Pharm Des; 2015; 21(34):5017-28. PubMed ID: 26205289
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
32. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis.
Pan J; Bian Y; Cao Z; Lei L; Pan J; Huang J; Cai X; Lan X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):329-335. PubMed ID: 31846184
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
[TBL] [Abstract][Full Text] [Related]
35.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.
Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S
Springerplus; 2016; 5(1):1721. PubMed ID: 27777857
[TBL] [Abstract][Full Text] [Related]
37. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia.
Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
Yuan M; Wang Y; Sun Q; Liu S; Xian S; Dai F; Zhang L; Fan Y; Wang F; Yang D; Zheng Y; Deng Z; Tan W; Liu Y; Cheng Y
Biomed Res Int; 2021; 2021():9798231. PubMed ID: 33506049
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
40. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
